Several case reports and cohort studies have recently investigated the potential association between bullous pemphigoid (BP) and psoriasis. It has been speculated that chronic inflammation in the dermo-epidermal junction can trigger exposure to antigens to autoreactive T cells, resulting in autoimmune blistering disease. However, the association described has been inconsistently reported amongst studies. We performed a systematic review and meta-analysis to investigation this potential association. We identified four case-control studies for inclusion in the present meta-analysis, with a total of 4035 bullous pemphigoid cases and 19 215 control cases. There was a significantly higher prevalence of psoriasis in BP compared to controls (2.6% vs 1.1%, OR 2.5, 95% CI 1.4-4.6). Subgroup analysis showed that this association remained significant in both males (3.0% vs 1.3%, OR 2.4, 95% CI 1.6-3.6) as well as females (1.9% vs 0.7%, OR 2.9, 95% CI 1.4-5.9). A significantly higher proportion of cases were reported in males (3.0% vs 1.9%, OR 1.75, 95% CI 1.1-2.7). This pooled analysis of existing case-control studies to date demonstrates a significant association between BP and psoriasis. We also showed that in contrast with the majority of autoimmune diseases which are predisposed in females, that the coexistence of BP and psoriasis appears to be predisposed in male patients.
INTRODUCTION
Bullous pemphigoid (BP) remains one of the most prevalent autoimmune bullous diseases. Despite the co-existence between bullous pemphigoid and psoriasis being first reported in 1929, 1 there remains a significant limitation in the understanding of the nature and mechanisms underlying this association. A multitude of autoimmune bullous diseases have been reported to co-exist with psoriasis including pemphigus vulgaris, pemphigus foliceous, pemphigus herpetiformis, linear bullous dermatoses, cicatricial pemphigoid, and epidermolysis bullosa acquisita. [2] [3] [4] [5] Although there is likely to be a significant genetic propensity toward autoimmune diseases in these patients, the precise triggering factors remain unknown. It has been suggested that chronic inflammation in the dermo-epidermal junction can trigger exposure to antigens to autoreactive T cells, resulting in BP. There has also been very limited published data comparing the demographics and comorbidities of BP patients who develop psoriasis versus those without co-existing psoriasis.
While females are known to be at higher risk than males for autoimmune diseases, it has been suggested that BP and psoriasis co-occur more often in males than females. 6 Many of the co-morbidities that occur in psoriasis patients are risk factors in later life for BP, including hypertension, cardiac and renal disease, with subsequent cerebrovascular disease and drugs to manage these conditions. It may be that there is an association between the two because of these co-morbidities, rather than psoriasis itself directly leading to BP.
To address current limitations in the available evidence, we performed a systematic review and meta-analysis of case-control studies to (i) determine if there is a significant association between BP and psoriasis, and (ii) whether there is a gender predisposition for this association.
MATERIALS AND METHODS

Literature search strategy
The present study was performed according to PRISMA guidelines. 7 As no human or animal subjects were involved in this study, ethics approval was not required. Electronic searches were performed using Ovid Medline, PubMed, Cochrane Central Register of Controlled Trials (CCTR), Cochrane Database of Systematic Reviews (CDSR), ACP Journal Club and Database of Abstracts of Review of Effectiveness (DARE) from their dates of inception to March 2018. The search strategy included a combination of the terms 'bullous pemphigoid' and 'psoriasis' as text terms or MeSH headings. The reference lists of all retrieved articles were reviewed for further identification of potentially relevant studies. All identified articles were systematically assessed using the inclusion and exclusion criteria.
Selection criteria
Case-control studies comparing BP versus control cohorts and reporting proportion of cases with psoriasis were eligible and included in the current study. BP and psoriasis were diagnosed either by a specialist dermatologist and/or histopathologically. Studies that did not include prevalence of psoriasis as an outcome were excluded from the present systematic review. When institutions published duplicate studies with accumulating numbers of patients or increased lengths of follow-up, only the most complete reports were included for quantitative assessment at each time interval. All publications were limited to those involving adult cases >18 years of age. Abstracts, case reports, conference presentations, editorials, and expert opinions were excluded. Review articles were omitted because of potential publication bias and duplication of results. Language was not an exclusion criteria for this systematic review.
Data extraction
All data were extracted from article texts, tables, and figures. Two investigators independently reviewed each retrieved article. Discrepancies between the two reviewers were resolved by discussion and consensus. The final results were reviewed by the senior investigator.
Statistical analysis
A random-effects meta-analysis of odds-ratio (OR) was conducted for the BP versus control cohorts cases with psoriasis. Heterogeneity was evaluated using the Cochrane Q and I 2 test. I 2 statistic was used to estimate the percentage of total variation across studies, owing to heterogeneity rather than chance. I 2 can be calculated as: I 2 = 100% 9 (Q À df)/Q, with Q defined as Cochrane's heterogeneity statistics and df defined as degree of freedom. Heterogeneity was defined as none (I 2 = 0%), low (I 2 = 25%), moderate (I 2 = 50%), or high (I 2 = 75%). In the present meta-analysis, the results using the random-effects model were presented to take into account the possible clinical diversity and methodological variation between studies. Specific analyses considering confounding factors were not possible because raw data were not available. All analyses were performed using Review Manager 5.3 (Cochrane Collaboration, Software Update, Oxford, United Kingdom). P values <0.05 were considered statistically significant.
RESULTS
Search strategy
A total of 787 studies were identified through electronic database searches. After exclusion of duplicate or irrelevant references, 778 potentially relevant articles were retrieved. After detailed evaluation of these articles, 56 studies remained for assessment. We identified four casecontrol studies [8] [9] [10] [11] for inclusion in the present meta-analysis, with a total of 4035 bullous pemphigoid cases and 19 215 control cases ( Table 1 ). The search strategy is outlined in Table S1 and Figure S1 .
Study characteristics
The four case-control studies were from four different regions around the world -France, Taiwan, United Kingdom, and Israel. Bastuji-Garin and colleagues 8 In this study, the controls and cases were not matched.
Other demographic features of cases and controls are summarized in Table 1 , although these were predominantly reported only from two studies. 8, 9 There were no significant differences between the cases and controls in 
Association between bullous pemphigoid and psoriasis
The pooled analysis reports a significantly higher prevalence of psoriasis in BP compared to controls (2.6% vs 1.1%, OR 2.5, 95% CI 1.4-4.6). Subgroup analysis showed that this association remained significant in both males (3.0% vs 1.3%, OR 2.4, 95% CI 1.6-3.6) as well as females (1.9% vs 0.7%, OR 2.9, 95% CI 1.4-5.9; Fig. 1) . A direct comparison of pooled psoriasis prevalence in male versus female BP cases demonstrated a significantly higher proportion of reported cases in males (3.0% vs 1.9%, OR 1.75, 95% CI 1.1-2.7; Fig. 2 ).
DISCUSSION
Bullous pemphigoid is a chronic debilitating autoimmune disorder which typically affects the elderly population. There has been a considerable amount of research focusing on BP-associated comorbidities. There is increasing evidence supporting the association between BP and neurological and psychiatric disorders. 12, 13 Although there have been previous suggestions of an association between BP and psoriasis, the evidence to date has been inconsistent and predominantly in the form of case reports and small case series. Providing evidence of this association is the first step in developing an understanding of the co-occurrence of BP and psoriasis, and may aid in early or preventative treatments to optimize management strategies.
From our pooled analysis of four studies, we found a significantly higher rate of psoriasis in BP compared to controls (OR 2.5). Subgroup analysis was performed to further investigate this significant association, which remained significant in both males and females. There was a significantly higher proportion of cases reported in males compared to females (OR 1.75). This evidence supports a male predilection for association between BP and psoriasis, in contrast with the female predisposition to the majority of autoimmune diseases. The mechanisms underlying this gender predisposition remains to be further characterized.
Whether BP induces psoriasis or vice versa remains to be studied. Kridin and Bergman 11 directly examined the coexistance of BP and psoriasis in a large cohort of patients with a recent BP diagnosis of 15 years. They found that the prevalence rate of psoriasis in patients with BP were significantly higher. Kridin and Bergman 11 noted that psoriasis preceded the diagnosis of bullous pemphigoid in all cases, suggesting that psoriasis may be the preceding risk factor for bullous pemphigoid. A literature review of 40 case reports by Wilczek and Sticherling 6 found that in the majority of cases, psoriasis was present before onset of BP. The average time interval was 20 years (range 1-60 years) between development of psoriasis to presentation of BP. 6 The underlying mechanisms of the association between BP and psoriasis is likely driven by autoimmune processes, but the precise nature of this is unknown. In the case of BP, specific auto-antibodies have been identified, however, in the case of psoriasis there have only been postulation and hypotheses regarding such mechanisms. These auto-autobodies include those against components of the Malpighian layer 14 and stratum corneum. 15 There may be other auto-antibodies stimulated by the dysregulated T-cell activity in psoriasis patients. Common to both autoimmune disorders however, is the disruption of the basement membrane integrity. One potential mechanism proposed is that BP antigens are unmasked in psoriasis through enzymatic degradation of the basement zone, which allows them to be accessible by circulating antibodies. 16 However, this does not provide a clear justification for BP blisters that are present on both psoriatic and normal-appearing skin in psoriasis patients. A common genetic predisposition has not been reported for BP and psoriasis thus far. 17 Additionally, psoriasis patients may be on a broad spectrum of treatment therapies, of which any agent may be a potential trigger factor for BP in psoriasis.
There have been some suggestions that UVB phototherapy and PUVA have effects on altering the antigenicity of the basement membrane, [18] [19] [20] which may trigger a bullouslike immunological response. The present review is constrained by several limitations. Firstly there is a significant lack of available literature directly addressing the relationship between BP and psoriasis. There is also considerable heterogeneity in the source of cases/control cases amongst the studies, and as such results should be interpreted with significant caution. For example we found moderate level heterogeneity when testing the association of psoriasis with BP in all patients not stratified (I 2 = 58%), with a greater proportion of weighting coming from the study by Chen and colleagues, which is a population based study where the ascertainment of both cases and controls were not perfect. Hospital-based recruitment of BP patients in the prospective study by Bastuji-Garin and colleagues 8 meant that there may be an inherent selection bias for more severe cases of BP, compared to the community setting. Diagnostic criteria for BP cases also varied, with three studies requiring both BP clinical features and histopathological or immunofluorescence for diagnosis, 8, 10, 11 and one study based on dermatologists' clinical diagnosis only. 9 Arguably, the latter based on insurance/government databases may not have completely accurate diagnostic coding for the BP cases, which undermines the validity of the data. There is also the possibility of ascertainment bias in the diagnosis of psoriasis. As suggested by Grattan, 10 there may be more likely documentation of psoriasis in the pemphigoid group, as treating clinicians and researchers may have been aware of possible association, and that the studies were nonblinded. This may have caused over-estimation of the point estimate, thus leading to statistical association between psoriasis and pemphigoid, a limitation which cannot be completely excluded. There were also limitations in the patients used for control groups. Two studies used a mixture of clinic-based and hospital-inpatients for control cases, 8, 11 one study used hospitalized inpatients only, 10 and one study used any visitor to the hospital as criteria for controls. This would result in variability in terms of how unwell the control group is and their inherent underlying comorbidities. It is expected that a more clinic-based control group would be healthier compared to hospitalized BP patients and this would skew the association of BP with psoriasis. Although the included studies attempted to mitigate some confounders via age and gender-matching, other baseline factors which can influence the prevalence of psoriasis, including diabetes, insulin resistance and BMI, and these were not accounted for in the present analyses. Additionally, some studies included in our analysis were retrospective in nature, which is susceptible to diagnostic bias and selection bias. In summary, our pooled analysis of existing case-control studies demonstrates a significant association between BP and psoriasis. We also showed that in contrast to the female predisposition to the majority of autoimmune diseases, the concomitance of BP and psoriasis is more common in male patients. These findings have implications for the management of BP patients.
